Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Hepatitis tests -- Image credit: Artyom | stock.adobe.com
FDA Grants Breakthrough Therapy Designation to Tobevibart With Elebsiran for Treatment of Chronic Hepatitis Delta

December 13th 2024

The treatments are currently undergoing evaluation in the SOLSTICE trial (NCT05461170).

Image Credit: © Yura Yarema - stock.adobe.com
FDA Grants Survodutide Breakthrough Therapy Designation for Treatment of Adults With MASH

October 8th 2024

Photomicrograph of liver biopsy in a patient with cirrhosis, showing bridging septal fibrosis and regenerative nodules.
FDA Grants Denifanstat Breakthrough Therapy Designation for Treatment of MASH

October 2nd 2024

Human liver anatomy with hepatitis B virus.
Minority of Hematology Patients Receive Hepatitis B Screening Prior to Intravenous Immunoglobulin Exposure

July 29th 2024

Image Credit: © eddows - stock.adobe.com
Persistent Epigenetic Changes in Immune Cells Following Hepatitis C Recovery

July 26th 2024

Video Interviews

More News